SCHEMBL6943774

SCHEMBL6943774

Cc1cc(-c2nsnc2OCCN2CCCCC2)ccc1Nc1c(C(=O)NOCC2CC2)cc(F)c(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
MAP2K1 Q02750 9/20 0.42
MAP2K2 P36507 2/20 0.39
RAF1 P04049 1/20 0.39
PDGFRB P09619 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
CSNK2A3 Q8NEV1 1/20 0.39
AURKC Q9UQB9 1/20 0.39
CAMK2A Q9UQM7 1/20 0.39
CHRNA7 P36544 1/20 0.35
KCNH2 Q12809 1/20 0.35
CNR2 P34972 1/20 0.34
AXL P30530 1/20 0.34
ABCB11 O95342 1/20 0.34
NQO2 P16083 1/20 0.34
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943566 0.92 MAP2K1 (0.47) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL6944936 0.83 MEN1 (0.67) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL7808212 0.83 MEN1 (0.35) MEN1KMT2ATDP1MAP2K1CNR2
SCHEMBL6946757 0.82 MEN1 (0.39) MEN1KMT2ATDP1KCNH2KDR
SCHEMBL6944622 0.77 MEN1 (0.67) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL6944483 0.76 MAP2K1 (0.57) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL24472623 0.75 MEN1 (0.82) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL29356577 0.73 MEN1 (1.00) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL1801637 0.73 MEN1 (1.00) MEN1KMT2ATDP1MAP2K1MAP2K2
SCHEMBL6947376 0.73 MEN1 (0.38) MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP claimed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP disclosed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP disclosed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed